Gelonghui, July 6?Shenlian Biology (688098.SH) announcedOn July 6, 2023, the company received the "explanation and apology on the change of shareholders' Rights and interests" and the "simplified Rights and interests change report" issued by the shareholder Shanghai Hongchao and its concerted actor Shanghai Fenghong. As of July 5, 2023, due to the reduction of shares by centralized bidding and block trading, the shareholding proportion of Shanghai Hongchao and its concerted actor Shanghai Fenghong has been reduced from 5.19% to 4.15%, and the proportion of equity change has exceeded 1%.
During the period from May 25, 2023 to July 5, 2023, Shanghai Hongchao and its concerted actor Shanghai Fenghong reduced a total of 4255800 shares of the company through centralized bidding and block trading, accounting for the total of the company.The proportion of equity is 1.04%, of which 225800 shares are reduced by centralized bidding, accounting for 0.06% of the company's total share capital, and 4030000 shares are reduced by bulk transactions, accounting for 0.98% of the company's total share capital.
Shanghai Hongchao, a shareholder of more than 5% of the company, and its concerted actor, Shanghai Fenghong, reduced their holdings by 4030000 shares, or 0.98%, through block trading on July 5, 2023, resulting in a total shareholding of less than 5%. Because the above-mentioned shareholders did not find that the total shareholding ratio had dropped to less than 5% in time after the reduction of their holdings, they failed to stop the transaction in time to fulfill the information disclosure obligation of changes in rights and interests. After self-examination, the company found the above illegal reduction and immediately notified the above-mentioned shareholders to submit a "simplified equity change report".